Prevalence of cirrhotic cardiomyopathy in patients with cirrhosis of liver.

  title={Prevalence of cirrhotic cardiomyopathy in patients with cirrhosis of liver.},
  author={S S Kumar},
  journal={The Journal of the Association of Physicians of India},
  volume={64 1},
  • S. S. Kumar
  • Published 20 January 2017
  • Medicine
  • The Journal of the Association of Physicians of India
Cirrhotic cardiomyopathy is impaired contractile responsiveness to stress, diastolic dysfunction and electrophysiological abnormalities in the absence of known cardiac disease in cirrhotic patients. This Descriptive case series study was conducted in sree balaji medical college and hospitals. This study included 74 consecutive cases of cirrhosis of liver of either sex above 14 years of age. Firstly, resting ECG was done in all the patients. QTc values were calculated from lead II. QTc interval… 



Cirrhotic cardiomyopathy among patients with liver cirrhosis

Provider awareness of CCM is needed since implementation of angiotensin receptor blocker and beta-blocker therapy early in the course of cirrhosis may modify the changes in cardiac function, and provider awareness of the cause of Cirrhotic cardiomyopathy is needed.

Cirrhotic cardiomyopathy

  • F. Wong
  • Medicine, Biology
    Hepatology international
  • 2009
Clinically, systolic incompetence is most evident when cirrhotic patients are placed under stress, whether physical or pharmacological, or when the extent of peripheral arterial vasodilatation demands an increased cardiac output as in the case of bacterial infections.

Cardiovascular complications of cirrhosis

Cardiovascular complications of cirrhosis include cardiac dysfunction and abnormalities in the central, splanchnic and peripheral circulation, and haemodynamic changes caused by humoral and nervous dysregulation, and the initiation of new randomised studies of potential treatments for these complications is needed.

Cirrhotic cardiomyopathy and liver transplantation

  • R. MyersSam Lee
  • Medicine, Biology
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2000
Evidence suggests that cirrhotic cardiomyopathy may be reversible after OLT, and the natural history of this condition warrants further investigation.

N-terminal Pro B-type Natriuretic Peptide and the Evaluation of Cardiac Dysfunction and Severity of Disease in Cirrhotic Patients

Plasma NT-proBNP levels were high in cirrhotic patients and are likely to be related to the severity of disease, which is associated with advanced cardiac dysfunction and cirrhosis progression.

The Use of E/A Ratio as a Predictor of Outcome in Cirrhotic Patients Treated With Transjugular Intrahepatic Portosystemic Shunt

Diastolic dysfunction, indicated by reduced E/A ratio, is prevalent in advanced cirrhosis and is associated with reduced ascites clearance and increased mortality post TIPS, possibly related to worsening of hemodynamic dysfunction in the post-TIPS period.

Cardiac abnormalities in liver cirrhosis.

  • S. S. Lee
  • Medicine
    The Western journal of medicine
  • 1989
Cirrhosis is associated with several circulatory abnormalities, and the release of atrial natriuretic peptide appears to be unimpaired in cirrhosis, although the kidney may be hyporesponsive to its natriUREtic effects.

The cardiac response to exercise in cirrhosis.

Impaired exercise capacity in cirrhosis is associated with myocardial thickening and ventricular stiffness leading to decreased diastolic function, inotropic and chronotropic incompetence under conditions of stress, with metabolic consequences.

Cardiovascular Dysfunction in Patients with End‐stage Liver Disease